[1]时晓华.丹参多酚酸盐注射液辅助介入治疗冠心病 及对患者心、肾功能和心肌损伤的影响*[J].陕西中医,2019,(5):568-571.
　SHI Xiaohua..Effects of salvianolate injection on cardiac function, renal function, myocardial injury in percutaneous coronary intervention postoperative patients with coronary heart disease[J].,2019,(5):568-571.
点击复制

丹参多酚酸盐注射液辅助介入治疗冠心病 及对患者心、肾功能和心肌损伤的影响*
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2019年5期
页码:
568-571
栏目:
临床研究
出版日期:
2019-05-05

文章信息/Info

Title:
Effects of salvianolate injection on cardiac function, renal function, myocardial injury in percutaneous coronary intervention postoperative patients with coronary heart disease
文章编号:
DOI:〖HT5K〗10.3969/j.issn.1000-7369.2019.05.007
作者:
时晓华
河南省直属机关第一门诊部全科医学科（郑州 450003）
Author(s):
SHI Xiaohua.
Department of General Medicine, First Outpatient Department of Henan Provincial Organs( Zhengzhou 450003)
关键词:
冠心病; 丹参多酚酸盐; 经皮冠脉介入治疗; 心功能; 肾功能; 心肌损伤
Keywords:
Coronary heart disease; Salvianolate; PCI; Cardiac function; Renal function; Myocardial injury
分类号:
R541.4
文献标志码:
A
摘要:
摘 要 目的：探讨丹参多酚酸盐注射液辅助经皮冠脉介入治疗（PCI）对冠心病患者心功能、肾功能及心肌损伤的影响，为冠心病临床诊治提供参考。方法： 选取需行PCI手术治疗的冠心病患者80例，将患者随机分为对照组与研究组两组，每组40例，两组患者均行PCI手术治疗，术前及术后常规用药，研究组在围术期同时给予丹参多酚酸盐注射液静脉滴注治疗，观察患者术后1个月内主要心血管事件（MACE）发生情况，患者术前与术后7 d时左室射血分数（LVEF）、左室舒张末期容量（LVEDV）、左室收缩末期容量（LVEsV）、血清肌酐（Scr）、胱抑素c（Cys-C）变化，术前及PCI术后24 h血肌钙蛋白I（cTnI）、肌酸激酶同工酶（CKMB）、脑钠肽（BNP）变化。结果：对照组术后发生8例MACE，MACE发生率为20.00%，研究组术后发生2例MACE，MACE发生率为5.00%，差异有统计学意义（P<0.05）；两组术前LVEF、LVEDV、LVEsV比较差异无统计学意义（P>0.05），术后7 d时两组LVEF均较术前明显升高（P<0.05），且研究组高于对照组（P<0.05），LVEDV、LVEsV均较术前下降（P<0.05），且研究组低于对照组（P<0.05）；两组术前血Scr、Cys-C比较差异无统计学意义（P>0.05），术后7 d时两组Scr、Cys-C均较术前明显升高（P<0.05），且对照组高于研究组（P<0.05）；两组术前cTnI、CKMB、BNP比较差异无统计学意义（P>0.05），术后24 h时两组cTnI、CKMB、BNP均较术前明显升高（P<0.05），且对照组高于研究组（P<0.05）。结论： PCI治疗冠心病在围术期给与丹参多酚酸盐注射液辅助治疗，有助于改善患者术后心功能、肾功能，减轻心肌损伤。
Abstract:
Abstract Objective: To investigate the effect of salvianolate injection on cardiac function, renal function, myocardial injury in percutaneous coronary intervention(PCI) postoperative patients with coronary heart disease,and provide the basis for clinic treatment of patients with coronary heart disease.Methods: We selected 80 cases of patients need PCI with coronary heart disease, they were randomly divided into control group (40 cases) and observation group (40 cases),and the two groups received PCI treatment,the observation group extra salvianolate injection for treatment in perioperative period.To observed major cardiovascular events (MACE) occurred in within 1 month after surgery,left ventricular ejection fraction (LVEF), left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVEsV), serum creatinine (Scr), cystatin c (Cys- c) in before and 7 d after surgery,serum troponin I (cTnI), creatine kinase isoenzyme (CKMB), brain natriuretic peptide (BNP) in before and 24h after surgery.Results:8 cases of MACE occurred postoperatively in the control group(20.00%),2 cases of MACE occurred postoperatively in the control group(5.00%),the difference was statistically significant (P<0.05).LVEF, LVEDV and LVEsV before surgery were not statistically significant between the two groups(P>0.05),LVEF of after surgery was significantly higher than those of before surgery of patients with the two groups (P<0.05),and the observation group was higher than the control group (P<0.05),LVEDV and LVEsV of after surgery were significantly lower than those of before surgery of patients with the two groups (P<0.05),and the observation group were〖LM〗 lower than the control group (P<0.05).Scr and Cys-C before surgery were not statistically significant between the two groups(P>0.05),Scr and Cys-C of after surgery were significantly higher than those of before surgery of patients with the two groups (P<0.05),and the observation group was higher than the control group (P<0.05).cTnI,CKMB and BNP before surgery were not statistically significant between the two groups(P>0.05),cTnI,CKMB and BNP of after surgery were significantly lower than those of before surgery of patients with the two groups (P<0.05),and the observation group was lower than the control group (P<0.05).Conclusion:PCI for the treatment of coronary heart disease was administered with salvianolate injection in the perioperative period,it is helpful to improve the cardiac and renal function and reduce the myocardial injury.

参考文献/References:

[1] 王 勇, 范书英. 冠心病介入治疗的现状和展望 [J]. 临床内科杂志, 2015,32 (1): 5-9.
[2] 邢文龙, 刘红旭, 尚菊菊, 等. 中医药干预 PCI 围手术期心肌损伤随机对照临床试验的系统综述 [J]. 北京中医药, 2017, 36(12): 1072-1075.
[3] 刘温华, 邓 斌, 李 荣, 等. 清热活血方对 PCI 术后患者对比剂相关肾功能损伤干预作用 [J]. 辽宁中医药大学学报, 2015, 17(6): 184-187.
[4] 赵彩霞, 靳会欣. 丹参多酚酸盐的药理作用机制及临床应用研究进展 [J]. 河北医药, 2017, 39(2): 294-299.
[5] Kanic V, Suran D, Vollrath M, et al. Influence of minor deterioration of renal function after PCI on outcome in patients with ST‐elevation myocardial infarction [J]. Journal of Interventional Cardiology, 2017, 30(5): 473-479.
[6] Sag S, YIldIz A, Kaderli A A, et al. Association of monocyte to HDL cholesterol level with contrast induced nephropathy in STEMI patients treated with primary PCI [J]. Clinical Chemistry and Laboratory Medicine (CCLM), 2017, 55(1): 132-138.
[7] 姚慧娟, 姚慧敏, 李莉霞, 等. 丹参多酚酸盐对 2 型糖尿病患者胰岛 β 细胞功能和血清抗氧化酶活性水平的影响 [J]. 中国医药导报, 2015, 12(10): 135-138.
[8] Zhou P, Gan C, Erfeng X. Salvianolate in elderly patients with unstable angina pectoris patient blood rheology and endothelial function [J]. Pract Clin Med, 2014, 17(1): 38-40.
[9] Tang Z, Tang X, Zeng G, et al. A clinical research of Salvianolate for treatment of coagulant function abnormality in patients with septic shock [J]. Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care, 2017, 24(1): 14-16.
[10] Luo X, Yang K, Huang Z, et al. Effect of Salvianolate combined with conventional therapy on acute ischemic stroke and influence on serum interleukin-6 [J]. China Pharmacist, 2017, 20(8): 1403-1405.
[11] Zhou S, Zhang F. Effects of salvianolate on the expression of VEGF and MMP-9 in lung tissue of mice with lung cancer [J]. China Pharmacy, 2016, 27(25): 3515-3517.
[12] Wen GB. Effect of salvianolate therapy on peripheral blood Bcl-2, BAX and Caspase-3 expression in patients with cerebral ischemic stroke and their correlation with neural function [J]. Journal of Hainan Medical University, 2017, 23(9): 138-142.
[13] 秦军燕, 王 琛, 杨 婧, 等. 5/6 肾切除大鼠残肾组织 HIF-1α, nNOS 蛋白表达及丹参多酚酸盐的作用机制 [J]. 中华肾脏病杂志, 2014, 30(2): 147-148.
[14] 温海滨, 覃 勋, 唐峰年, 等．丹参多酚酸盐预处理对肾小管上皮细胞凋亡的保护机制 [J]. 中国中西医结合肾病杂志, 2013, 14(11):997-999.

相似文献/References:

[1]朱 薇.通脉调脂方治疗冠心病稳定性心绞痛疗效及对患者血流变、VCAM1〖JZ〗及ICAM1影响的研究*[J].陕西中医,2019,(3):290.
　ZHU Wei..Effect of Tongmai Tiaozhi recipe on the efficacy, Hemorheology, VCAM1 and ICAM1 〖JZ〗in patients with stable angina pectoris of coronary heart disease[J].,2019,(5):290.
[2]孙 哲,杨 默,石宗华.丹参多酚酸盐与丹参酮治疗慢性心力衰竭临床研究[J].陕西中医,2019,(5):591.
　SUN Zhe,YANG Mo,SHI Zonghua..Clinical effect and mechanism of salvianolate and Tanshinone in the treatment of chronic heart failure[J].,2019,(5):591.
[3]刘 红,张玲燕,杨 玲.血府逐瘀汤治疗冠心病介入术后心绞痛临床研究[J].陕西中医,2019,(5):594.
　LIU Hong,ZHANG Lingyan,YANG Ling..Clinical observation of Xuefu Zhuyu decoction in the treatment of angina pectoris after PCI for coronary heart disease[J].,2019,(5):594.
[4]吕永飞,陈爱莲.益心康泰胶囊治疗冠心病经皮冠状动脉介入术术后疗效及对患者血流变、血管内皮功能的影响*[J].陕西中医,2019,(6):714.
　LV Yongfei,CHEN Ailian..Effect of Yixin Kangtai capsule on the curative effect hemorheology and vascular endothelial function after coronary artery disease PCI[J].,2019,(5):714.
[5]贺建涛,胡宇才,刘 磊.活血通络散治疗冠心病PCI术后心绞痛疗效研究*[J].陕西中医,2019,(7):854.
　HE Jiantao,HU Yucai,LIU Lei..Efficacy observation of Huoxue Tongluo powder in the treatment of angina pectoris after coronary heart disease PCI[J].,2019,(5):854.
[6]董玉任,李拥军,罗松平,等.丹参多酚酸盐在急诊患者缺血性心肌损伤治疗中的应用[J].陕西中医,2019,(7):871.
　DONG Yuren,LI Yongjun,LUO Songping,et al.Application of Salvia miltiorrhiza polyphenolate inemergency patients with ischemic myocardial injury[J].,2019,(5):871.
[7]解洪涛,张 顺△,曾广伟.当归补血方联合西药治疗冠脉搭桥术后疗效及对患者血瘀证证候评分和凝血功能的影响*[J].陕西中医,2019,(10):1341.
　XIE Hongtao,ZHANG Shun,ZENG Guangwei..Effects of Danggui Buxue prescription combined with western medicine on blood stasis and coagulation function after coronary artery bypass grafting[J].,2019,(5):1341.
[8]索晓菲,王亚红△,王居新,等.软坚通脉汤治疗冠心病PCI术后Ⅱ期心脏康复疗效〖JZ〗及对患者生活质量的影响*[J].陕西中医,2020,(1):29.
[9]尹 毅,李小兰△.益气活血汤联合尼可地尔治疗稳定性心绞痛疗效及对患者T淋巴细胞亚群的影响[J].陕西中医,2020,(7):888.[doi:DOI:10.3969/j.issn.10007369.2020.07.014]
[10]季学清,刘 萍△,陈宝瑾,等.冠心康方加减联合西药治疗冠心病合并2型糖尿病气虚痰瘀证疗效研究*[J].陕西中医,2020,(9):1208.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.008]
　JI Xueqing,LIU Ping,CHEN Baojin,et al.Efficacy of Guanxinkang preparation combined with western medicine in the treatment of coronary heart disease and type 2 diabetes mellitus with syndrome of Qixu Tanyu[J].,2020,(5):1208.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.008]

备注/Memo

备注/Memo:
*河南省医学科技攻关计划项目（201608921）
更新日期/Last Update: 2019-05-07